These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31770615)

  • 1. Immunohistochemical staining with chemokine panel of non-specific colitis predicts future IBD diagnosis.
    El-Saka AM; Zamzam YA; Haydara T; Abd-Elsalam S
    Cytokine; 2020 Mar; 127():154935. PubMed ID: 31770615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines as novel therapeutic targets for inflammatory bowel disease.
    Nishimura M; Kuboi Y; Muramoto K; Kawano T; Imai T
    Ann N Y Acad Sci; 2009 Sep; 1173():350-6. PubMed ID: 19758172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases.
    Derkacz A; Olczyk P; Komosinska-Vassev K
    Dis Markers; 2018; 2018():7451946. PubMed ID: 29991970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of microRNA-155 in inflammatory bowel disease and its clinical significance].
    Ye YL; Pang Z; Gu W; Zheng JJ
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3716-3719. PubMed ID: 29325325
    [No Abstract]   [Full Text] [Related]  

  • 10. Difficult differential diagnoses in IBD: ileitis and indeterminate colitis.
    Legnani PE; Kornbluth A
    Semin Gastrointest Dis; 2001 Oct; 12(4):211-22. PubMed ID: 11726075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal mucosal nitric oxide in differentiation of inflammatory bowel disease and irritable bowel syndrome.
    Reinders CI; Herulf M; Ljung T; Hollenberg J; Weitzberg E; Lundberg JO; Hellström PM
    Clin Gastroenterol Hepatol; 2005 Aug; 3(8):777-83. PubMed ID: 16234006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Clinical findings and early diagnosis.
    Schumacher G; Sandstedt B; Kollberg B
    Scand J Gastroenterol; 1994 Mar; 29(3):265-74. PubMed ID: 8209188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus colitis in patients without inflammatory bowel disease: a single center study.
    Kim CH; Bahng S; Kang KJ; Ku BH; Jo YC; Kim JY; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim YH
    Scand J Gastroenterol; 2010 Nov; 45(11):1295-301. PubMed ID: 20568970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.
    Wasinger VC; Yau Y; Duo X; Zeng M; Campbell B; Shin S; Luber R; Redmond D; Leong RW
    Mol Cell Proteomics; 2016 Jan; 15(1):256-65. PubMed ID: 26530476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.
    de Jong MJ; Roosen D; Degens JHRJ; van den Heuvel TRA; Romberg-Camps M; Hameeteman W; Bodelier AGL; Romanko I; Lukas M; Winkens B; Markus T; Masclee AAM; van Tubergen A; Jonkers DMAE; Pierik MJ
    J Crohns Colitis; 2019 Apr; 13(5):555-563. PubMed ID: 30476099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.